Skip to main content
Clinical Trials/JPRN-UMIN000009621
JPRN-UMIN000009621Completed未知

An exploratory research investigating the appropriate usage and clinical evaluation of compound Monoammonium glycyrrhizinate Glycine DL-Methionine tablet on mild alopecia areata - An exploratory research investigating the appropriate usage and clinical evaluation of compound Monoammmonium glycyrrhizinate Glycine DL-Methionine tablet on mild alopecia areata

Institute of Health Biosciences ,The University of Tokushima Graduate School0 sites30 target enrollmentStarted: December 28, 2012Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1)Patients who have advanced eczema and/or dermatitis of the scalp 2)Patients in whom three or more hairs are lost in hair pull test 3)Patients who have received oral steroid treatment, inhalation treatment, local steroid injection, or external steroid treatment for scalp within one month before the date of informed consent 4)Patients who have used medical products that claim promotion of hair growth, prevention of hair loss, or hair restoration action within one month before the date of informed consent 5)Patients with a history of allergic reaction to carpronium or glycyrrhizin 6)Patients diagnosed with malignant tumor 7)Patients with serious liver, renal, or cardiac disease 8)Patients who are breast-feeding, pregnant, possibly pregnant, or plan to become pregnant during the study period 9)In addition, patients who are determined as ineligible by the study doctor

Investigators

Sponsor
Institute of Health Biosciences ,The University of Tokushima Graduate School

Similar Trials